Fusconi M, Ghadiminejad I, Bianchi F B, Baum H, Bottazzo G F, Pisi E
Instituto di Clinica Medica Generale, University of Bologna, Italy.
Gut. 1988 Apr;29(4):440-7. doi: 10.1136/gut.29.4.440.
Seventy seven sera with antimitochondrial antibody exhibiting the M2-M4 pattern in immunofluorescence (56 from primary biliary cirrhosis (PBC), 21 from non-primary biliary cirrhosis patients) were studied by the combined use of Western immunoblotting with beef heart mitochondria and an enzyme linked immunosorbent assay (ELISA) with beef heart submitochondrial particles. Forty seven sera (10 without autoantibodies and 37 with different auto-antibodies) were included as controls. By immunoblotting, seven mitochondrial peptides reacting with antimitochondrial antibody positive sera were detected. These were of molecular weight 74 kD, 58 kD, 55 kD, 52 kD, 51 kD, 46 kD, and 43 kD. All primary biliary cirrhosis sera and 71% of antimitochondrial antibody-positive non-primary biliary cirrhosis sera reacted with one or more of these peptides, while none of the 47 antimitochondrial antibody negative sera reacted in immunoblotting. The 74 kD band was the most frequently detected (84% of primary biliary cirrhosis and 57% of non-primary biliary cirrhosis cases). All the primary biliary cirrhosis sera which failed to react with this peptide, showed a positive reaction with that of molecular weight 52 kD. 67/77 (87%) immunofluorescence antimitochondrial antibody positive sera reacted in the ELISA test (93% of primary biliary cirrhosis and 71% of non-primary biliary cirrhosis cases). All the 47 immunofluorescence antimitochondrial antibody negative sera were confirmed negative by ELISA. The ELISA values correlated with the immunofluorescence titres (p less than 0.05). By comparison of the results obtained by these two techniques, it emerged that the ELISA test (using our preparation of submitochondrial particles) was not able to detect the antibody directed against the mitochondrial peptide of 52 kD, which thus seems to be different from the other specificities.
采用牛肉心线粒体免疫印迹法与牛肉心亚线粒体颗粒酶联免疫吸附测定法(ELISA)相结合的方法,对77份在免疫荧光中呈现M2 - M4模式的抗线粒体抗体血清进行了研究(56份来自原发性胆汁性肝硬化(PBC),21份来自非原发性胆汁性肝硬化患者)。47份血清(10份无自身抗体,37份有不同自身抗体)作为对照。通过免疫印迹法,检测到7种与抗线粒体抗体阳性血清反应的线粒体肽。这些肽的分子量分别为74 kD、58 kD、55 kD、52 kD、51 kD、46 kD和43 kD。所有原发性胆汁性肝硬化血清以及71%的抗线粒体抗体阳性非原发性胆汁性肝硬化血清与其中一种或多种肽发生反应,而47份抗线粒体抗体阴性血清在免疫印迹中均无反应。74 kD条带检测频率最高(原发性胆汁性肝硬化病例中占84%,非原发性胆汁性肝硬化病例中占57%)。所有未与该肽反应的原发性胆汁性肝硬化血清,均与分子量为52 kD的肽呈阳性反应。67/77(87%)免疫荧光抗线粒体抗体阳性血清在ELISA检测中呈阳性反应(原发性胆汁性肝硬化病例中占93%,非原发性胆汁性肝硬化病例中占71%)。所有47份免疫荧光抗线粒体抗体阴性血清经ELISA证实为阴性。ELISA值与免疫荧光滴度相关(p小于0.05)。通过比较这两种技术获得的结果发现,ELISA检测(使用我们制备的亚线粒体颗粒)无法检测到针对52 kD线粒体肽的抗体,因此该抗体似乎与其他特异性不同。